Clinical Trials Browser

Phase 3 × Multiple Myeloma × pembrolizumab × Clear all

NCT02576977 2021-10-08

KEYNOTE 183

Phase 3 Terminated

251 enrolled 17 charts

Multiple Myeloma

NCT02579863 2021-07-20

KEYNOTE 185

Phase 3 Terminated

310 enrolled 16 charts

Multiple Myeloma